Financial Daily from THE HINDU group of publications
Friday, Nov 04, 2005


Group Sites

Corporate - Courts/Legal Issues

UK court permits Ranbaxy to appeal Lipitor verdict

Our Bureau

New Delhi , Nov. 3

RANBAXY Laboratories Ltd today said that the UK High Court had granted it permission to appeal the October 12 judgment stating that its atorvastatin product would infringe Pfizer's European patent.

The court had upheld the exclusivity until November 2011of the main patent covering the active ingredient of atorvastatin — a cholesterol-lowering drug, which is marketed by Pfizer as Lipitor. It also ruled invalid another patent, which covers the calcium salt of atorvastatin.

In his decision today, Mr Justice Pumfrey granted permission to both Ranbaxy and Pfizer to appeal the respective rulings in the UK Court of Appeal. The outcome of both appeals is expected by the end of 2006.

Mr Malvinder Singh, President and Executive Director, Ranbaxy, said, "Having already been successful in invalidating one of the two key Pfizer patents relating to atorvastatin in the UK, Ranbaxy is encouraged to have been granted the opportunity to make its case on the infringement decision on the other patent before the UK Court of Appeal. We remain committed to our objective of bringing an affordable generic formulation of atorvastatin to the National Health Service in the UK."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Tata Safari Dicor

Stories in this Section
Nagarjuna Power may award O&M contract to strategic investor

ONGC decides against special dividend — May consider interim dividend later
BHEL bags Rs 130-cr IOC order
PowerGrid gets $400-m ADB loan
UK court permits Ranbaxy to appeal Lipitor verdict
Danish co acquires 60 pc equity in Pennar Profiles
Sentini group plans Rs 300-cr expansion programme
KPMG joint venture for sourcing Indian experts
Investment arm: Coal India hopeful of early approval
MoU with ONGC on gasification

Shalimar Paints teams up with Kunsul Chemical
Grover Vineyards hopes to raise Rs 15 cr via stake sale
Indian Seamless bets big on exports
Coal India H1 profit up at Rs 2,828 cr
VSP sales turnover up
Maruti domestic sales up
GM sales rise marginally
Hindustan Zinc non-exec chief

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line